- Report
- October 2024
- 195 Pages
Global
From €3181EUR$3,545USD£2,738GBP
€3534EUR$3,939USD£3,042GBP
- Report
- May 2024
- 130 Pages
Global
From €5831EUR$6,499USD£5,019GBP
- Report
- May 2024
- 138 Pages
Global
From €5831EUR$6,499USD£5,019GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €1346EUR$1,500USD£1,158GBP
- Report
- October 2023
- 26 Pages
Global
€10992EUR$12,250USD£9,460GBP
- Report
- January 2024
- 86 Pages
Global
From €3500EUR$4,178USD£3,118GBP
- Book
- January 2010
- 616 Pages
Sotalol is a medication used to treat abnormal heart rhythms, such as atrial fibrillation and atrial flutter. It is a type of antiarrhythmic drug, which works by blocking certain electrical signals in the heart that can cause an irregular heartbeat. Sotalol is also used to treat ventricular tachycardia, a condition in which the heart beats too quickly. It is available in both oral and intravenous forms.
Sotalol is a commonly prescribed cardiovascular drug, and is used to treat a variety of heart rhythm disorders. It is generally well-tolerated, and has few side effects. It is also relatively inexpensive, making it an attractive option for many patients.
In the Sotalol market, there are several companies that produce and distribute the drug. These include Mylan, Teva Pharmaceuticals, Sandoz, and Apotex. Additionally, there are several generic versions of the drug available, produced by various manufacturers. Show Less Read more